Physician profile
David Lish
NPI 1558920918
$2,853.01
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $790 · 2021: $577 · 2022: $876.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $473.94 | 2020-2022 | |
| Stryker Corporation | $367.49 | 2021-2022 | |
| Horizon Therapeutics Plc | $275.53 | 2019-2022 | |
| Medical Device Business Services, INC. | $243.00 | 2020 | |
| Paragon 28, INC. | $217.56 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $194.31 | 2019-2020 | |
| Cardiovascular Systems INC. | $184.19 | 2021-2022 | |
| Depuy Synthes Sales INC. | $155.63 | 2019-2020 | |
| Heron Therapeutics, INC. | $121.92 | 2021 | |
| Smith+Nephew, INC. | $109.53 | 2022 | |
| Organogenesis INC. | $109.45 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $102.41 | 2019 | |
| Medline Industries LP | $97.07 | 2022 | |
| Integra Lifesciences Corporation | $84.84 | 2019 | |
| Kci USA, INC. | $68.93 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $30.04 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.17 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.